Product
Gliclazide
Aliases
metformin
4 clinical trials
5 indications
Indication
Diabetes Mellitus Type 2Indication
Diabetic Nephropathy Type 2Indication
Type 2 Diabetes MellitusIndication
Mild Cognitive ImpairmentIndication
Cognitive DysfunctionClinical trial
Does Glycated Hemoglobin Variability in Type 2 Diabetes Differ Depending on the Diabetes Treatment Threshold Used in the Qatari Population: Implication on Diabetes Complication Risk?Status: Active (not recruiting), Estimated PCD: 2023-10-01
Clinical trial
A Multicentric, Prospective, Randomized Study Evaluating the Improvement of Renal Function Outcomes With Dorzagliatin in Patients With Type 2 Diabetes Mellitus With Early Kidney Injury.Status: Not yet recruiting, Estimated PCD: 2025-05-31
Clinical trial
A Prospective, Randomized, Open Label, Parallel, 6-month Study to Explore and Evaluate the Therapeutic Effects of Henagliflozin on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in T2DM Patients With Mild Cognitive Impairment.Status: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Efficacy Comparison of Polyethylene Glycol Loxenatide and Gliclazide on the Brain Function in T2DM Patients: a Randomized, Parallel Controlled Clinical TrialStatus: Recruiting, Estimated PCD: 2024-02-01